Urologic Oncology Research Symposium: Tumor Microenvironment and Immunology: Frontiers in Cancer Therapy

Forum

Combination Immunotherapy for Prostate Cancer: OX40 Agonists, Checkpoint Blockade, and Beyond

Friday, May 18
2:45 PM - 3:05 PM
Location: MCC SOUTH, 208

William L. Redmond

Presentation(s):

Send Email for William Redmond


Assets

Combination Immunotherapy for Prostate Cancer: OX40 Agonists, Checkpoint Blockade, and Beyond



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Combination Immunotherapy for Prostate Cancer: OX40 Agonists, Checkpoint Blockade, and Beyond